To further analyze the relationship between CRABP2 and the prognosis of ovarian cancer patients, we used immunohistochemistry to detect the protein expression level of CRABP2 in tumor tissues from 128 patients with serous ovarian cancer (Fig. 1C). Here, CRABP2 is linked to ovarian carcinoma.